BrainStorm Issues 2024 Letter to Shareholders
Provided By PR Newswire
Last update: Dec 30, 2024
NEW YORK, Dec. 30, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issued a Letter to shareholders.
Read more at prnewswire.comNASDAQ:BCLI (4/22/2025, 8:00:00 PM)
0.8758
+0.02 (+1.84%)
Find more stocks in the Stock Screener
BCLI Latest News and Analysis
12 days ago - ChartmillOn Friday, there are stocks with unusual volume. Let's take a look.Unusual volume stocks in Friday's session
